Paratek Pharmaceuticals, Inc. Quarterly Costs and Expenses in USD from Q2 2010 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
Paratek Pharmaceuticals, Inc. quarterly/annual Costs and Expenses history and growth rate from Q2 2010 to Q2 2023.
  • Paratek Pharmaceuticals, Inc. Costs and Expenses for the quarter ending June 30, 2023 was $49.4M, a 15.4% increase year-over-year.
  • Paratek Pharmaceuticals, Inc. Costs and Expenses for the twelve months ending June 30, 2023 was $222M, a 24% increase year-over-year.
  • Paratek Pharmaceuticals, Inc. annual Costs and Expenses for 2022 was $206M, a 20.5% increase from 2021.
  • Paratek Pharmaceuticals, Inc. annual Costs and Expenses for 2021 was $171M, a 39.9% increase from 2020.
  • Paratek Pharmaceuticals, Inc. annual Costs and Expenses for 2020 was $122M, a 7.37% decline from 2019.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2023 $222M $49.4M +$6.6M +15.4% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-03
Q1 2023 $215M $47M +$8.47M +22% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-09
Q4 2022 $206M $78.4M +$19.3M +32.7% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-16
Q3 2022 $187M $46.7M +$8.54M +22.4% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $179M $42.8M -$598K -1.38% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 $179M $38.6M +$7.93M +25.9% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $171M $59.1M +$25.5M +76.1% Oct 1, 2021 Dec 31, 2021 10-K 2022-03-14
Q3 2021 $146M $38.2M +$8.56M +28.9% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $137M $43.4M +$15.6M +56.3% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-03
Q1 2021 $122M $30.6M -$850K -2.7% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q4 2020 $122M $33.6M +$1.4M +4.36% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-14
Q3 2020 $121M $29.6M -$3.34M -10.1% Jul 1, 2020 Sep 30, 2020 10-K 2022-03-14
Q2 2020 $124M $27.8M -$4.39M -13.7% Apr 1, 2020 Jun 30, 2020 10-K 2022-03-14
Q1 2020 $129M $31.5M -$3.42M -9.78% Jan 1, 2020 Mar 31, 2020 10-K 2022-03-14
Q4 2019 $132M $32.1M -$4.9M -13.2% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-29
Q3 2019 $137M $32.9M +$3.28M +11.1% Jul 1, 2019 Sep 30, 2019 10-K 2021-03-29
Q2 2019 $134M $32.2M +$4.4M +15.8% Apr 1, 2019 Jun 30, 2019 10-K 2021-03-29
Q1 2019 $129M $34.9M +$8.19M +30.7% Jan 1, 2019 Mar 31, 2019 10-K 2021-03-29
Q4 2018 $121M $37.1M +$11.1M +42.8% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-10
Q3 2018 $110M $29.7M +$9.35M +46% Jul 1, 2018 Sep 30, 2018 10-K 2020-03-10
Q2 2018 $101M $27.8M +$3.61M +14.9% Apr 1, 2018 Jun 30, 2018 10-K 2020-03-10
Q1 2018 $97.1M $26.7M -$67K -0.25% Jan 1, 2018 Mar 31, 2018 10-K 2020-03-10
Q4 2017 $97.2M $25.9M +$21K +0.08% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-06
Q3 2017 $97.2M $20.3M -$2.8M -12.1% Jul 1, 2017 Sep 30, 2017 10-K 2019-03-06
Q2 2017 $100M $24.2M -$5.59M -18.8% Apr 1, 2017 Jun 30, 2017 10-K 2019-03-06
Q1 2017 $106M $26.8M -$3.94M -12.8% Jan 1, 2017 Mar 31, 2017 10-K 2019-03-06
Q4 2016 $110M $25.9M +$5.55M +27.2% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-06
Q3 2016 $104M $23.1M -$259K -1.11% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-06
Q2 2016 $104M $29.8M +$14.1M +89.8% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-06
Q1 2016 $90.2M $30.7M +$20.1M +189% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-06
Q4 2015 $70.1M $20.4M +$14.5M +245% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-02
Q3 2015 $55.6M $23.4M +$20.3M +660% Jul 1, 2015 Sep 30, 2015 10-K 2017-03-02
Q2 2015 $35.3M $15.7M +$13.5M +621% Apr 1, 2015 Jun 30, 2015 10-K 2017-03-02
Q1 2015 $21.8M $10.6M +$9.65M +986% Jan 1, 2015 Mar 31, 2015 10-K 2017-03-02
Q4 2014 $12.1M $5.91M +$217K +3.81% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-09
Q3 2014 $11.9M $3.08M -$1.99M -39.3% Jul 1, 2014 Sep 30, 2014 10-K 2016-03-09
Q2 2014 $13.9M $2.18M -$4.72M -68.4% Apr 1, 2014 Jun 30, 2014 10-K 2016-03-09
Q1 2014 $18.6M $979K -$3.67M -78.9% Jan 1, 2014 Mar 31, 2014 10-K 2016-03-09
Q4 2013 $22.3M $5.69M +$511K +9.86% Oct 1, 2013 Dec 31, 2013 10-K 2014-03-14
Q3 2013 $21.8M $5.07M -$472K -8.52% Jul 1, 2013 Sep 30, 2013 10-Q 2014-10-28
Q2 2013 $22.3M $6.89M +$1.3M +23.3% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-06
Q1 2013 $21M $4.65M -$496K -9.65% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-05
Q4 2012 $21.5M $5.18M -$2.31M -30.8% Oct 1, 2012 Dec 31, 2012 10-K 2014-03-14
Q3 2012 $23.8M $5.54M -$47K -0.84% Jul 1, 2012 Sep 30, 2012 10-K 2014-03-14
Q2 2012 $23.8M $5.59M +$245K +4.58% Apr 1, 2012 Jun 30, 2012 10-K 2014-03-14
Q1 2012 $23.6M $5.14M +$106K +2.11% Jan 1, 2012 Mar 31, 2012 10-K 2014-03-14
Q4 2011 $23.5M $7.49M Oct 1, 2011 Dec 31, 2011 10-K 2013-03-12
Q3 2011 $5.59M -$282K -4.81% Jul 1, 2011 Sep 30, 2011 10-K 2013-03-12
Q2 2011 $5.35M +$169K +3.27% Apr 1, 2011 Jun 30, 2011 10-K 2013-03-12
Q1 2011 $5.04M Jan 1, 2011 Mar 31, 2011 10-K 2013-03-12
Q3 2010 $5.87M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-10
Q2 2010 $5.18M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.